Skip to main content
. 2022 Jul 1;26(7):567–576. doi: 10.5152/AnatolJCardiol.2022.1597

Table 3.

Follow-up Results, HASBLED Score, and TTR Results

CHA2DS2-VASc Score Risk Classification Low-Medium Risk (n = 349) High Risk (n = 2243) P Total (n = 2592)
Follow-up time (day) 2072 (1197-2188) 1626 (880-2130) <.001 1920 (939-2133)
Ischemic CVD/TIA in follow-up, n (%) 6 (1.7) 136 (6.1) .001 14(5.5)
Hemorrhagic CVD in follow-up, n (%) 1 (0.3) 11 (0.5) .505 12 (0.5)
Death at first-year follow-up, n (%) 6 (1.7) 231 (10.3) <.001 237 (9.1)
Death at fifth-year follow-up, n (%) 36 (10.3) 725 (32.3) <.001 761 (29.4)
HASBLED score 0 (0-1) 2 (1-2) <.001 1 (1-2)
TTR (%) 49.0 (26-85.4) 40 (22.8-70) .163 40 (23-70)

P value of <.05 shows statistical significance.

CVD, cerebrovascular disease; TIA, transient ischemic attack; TTR, time in therapeutic range.